Details
 

March 10, 2024
8:15AM - 12:00PM EDT

Spring CE Webinar

2024SpringWebinar

Join us on a Sunday morning for an enriching virtual learning experience, leaving your afternoon free for enjoyable moments with family and friends.

Register Now!


Registration Fees

OD Member $100
OD Non-member $150
Para Member $15
Para Non-member $30


Continuing Education Agenda

 

8:15 AM – 8:30 AM   
Introduction & Welcome

8:30 AM – 10:10 AM  
Opioid Pain Management*
Tracy Offerdahl, PharmD, BPharm, RPh, FAAO

2 NJSBO Oral Credits (* this course satisfies the one-hour NJSBO Opioid education requirement)
– NJSBO # 660-2025

This course describes the appropriate use of opioid medications, with an emphasis on pain management within the scope of optometry and general pain management. Case anecdotes will include management of ocular pain, with specific emphasis on oral/systemic medications. Opioid medications will be evaluated in terms of risk versus benefit, with an emphasis on appropriate use of pain medications, evaluation of potential addiction, and a description on how to protect both patient and practitioner.

10:10 AM – 10:30 AM 
Virtual Coffee Break

10:30 AM – 11:20 AM
Optometry’s Role in Cancer Treatment: New Cancer Medications and Their Most Common Ocular Side Effects
Julia Canestraro, OD, FAAO

1 NJSBO Oral Credit – NJSBO # 661-2025

Human cancers are increasingly being treated with molecularly targeted agents, a novel way to approach cancer treatment. As more drugs are FDA approved, they are becoming widely available and is something we will encounter as eye care providers. Many of these drugs require regular ocular toxicity monitoring – and optometrists should know how to diagnose, manage, and treat patients with drug-induced ocular toxicity. This course will introduce those FDA drugs and their potential ocular toxicities with real-patient examples and overview how they should be managed.

11:20 AM – 12:10 PM
Top 5 Cancers in the US – What it Means for the Patient in Your Chair

Julia Canestraro, OD, FAAO

1 NJSBO TPA Credit – NJSBO # 662-2025

This course will cover how to screen for ocular manifestations of the top 5 most common cancers in the U.S., including their treatment and management.

IMPORTANT INFORMATION REGARDING CE CREDIT:
Courses presented at this event will be New Jersey State Board of Optometrists (NJSBO) and are non-COPE courses. Courses will be accepted for CE credit in NJ, NY, and PA. If you are licensed in any other state, please check with that state's Optometry Board to inquire if these courses will be accepted.


Meet the Speakers 

Tracy Offerdahl, PharmD, BPharm, RPh, FAAO


Dr. Offerdahl attended Temple University School of Pharmacy in Philadelphia, Pennsylvania for both her undergraduate and graduate degrees. Upon completion of her Doctor of Pharmacy degree, she completed a residency at Temple University Hospital. She is currently on faculty at Salus University in the Department of Optometry, where she is the course director and instructor for all systemic pharmacology courses for students in the optometry, audiology, and physician assistant programs. Additionally, she is a practicing clinical pharmacist.

Julia Canestraro, OD, FAAO

Dr. Canestraro graduated from SUNY College of Optometry, and is currently an assistant attending optometrist at Memorial Sloan Kettering Cancer Center, Ophthalmic Oncology Service. She has experience in the diagnosis and non-surgical management of ocular disease, including ocular tumors. She also specializes in treating the ocular consequences of cancer and its treatments. 

 


Industry Support!

2-7-24 Partners

Sponsor Videos

Check out this short PECAA member experience video from 2024 Diamond Partner, PECAA.

View charitable eye care initiatives in a video from NJSOP Gold Partner, VSP.

Learn about a contact lens option in a video from NJSOP Gold Partner, Johnson and Johnson.
ACUVUE® OASYS MAX 1-Day contact lenses uses an unprecedented combination of technologies to deliver all-day comfort and visual clarity, day to night

 

 


NJSOP CE Event Registration Refund Policy

 
In the event an NJSOP continuing education event attendee wishes to rescind their event registration, refunds may be requested through email or by mail to NJSOP. Refund requests received at least 30 days or more before the event will receive a full refund. Requests made 14-29 days before the event will receive a 50% refund. Refunds will not be issued within 14 days of the event. However, registered attendees who experience an extenuating circumstance that prevents them from attending the event can request refund consideration via email or by mail. Refunds will be provided in the manner in which the registered attendee paid.  

 

 

Printer-Friendly Version


Add to Calendar aCLuDhaqizCaPxAftmqF167204 03/10/2024 08:15 AM 03/10/2024 12:00 PM false America/New_York Spring CE Webinar Join us on a Sunday morning for an enriching virtual learning experience, leaving your afternoon free for enjoyable moments with family and friends. Register Now! Registration Fees OD Member $100OD Non-member $150Para Member $15Para Non-member $30 Continuing Education Agenda   8:15 AM – 8:30 AM    Introduction & Welcome 8:30 AM – 10:10 AM   Opioid Pain Management*Tracy Offerdahl, PharmD, BPharm, RPh, FAAO 2 NJSBO Oral Credits (* this course satisfies the one-hour NJSBO Opioid education requirement) – NJSBO # 660-2025 This course describes the appropriate use of opioid medications, with an emphasis on pain management within the scope of optometry and general pain management. Case anecdotes will include management of ocular pain, with specific emphasis on oral/systemic medications. Opioid medications will be evaluated in terms of risk versus benefit, with an emphasis on appropriate use of pain medications, evaluation of potential addiction, and a description on how to protect both patient and practitioner. 10:10 AM – 10:30 AM  Virtual Coffee Break 10:30 AM – 11:20 AM Optometry’s Role in Cancer Treatment: New Cancer Medications and Their Most Common Ocular Side EffectsJulia Canestraro, OD, FAAO 1 NJSBO Oral Credit – NJSBO # 661-2025 Human cancers are increasingly being treated with molecularly targeted agents, a novel way to approach cancer treatment. As more drugs are FDA approved, they are becoming widely available and is something we will encounter as eye care providers. Many of these drugs require regular ocular toxicity monitoring – and optometrists should know how to diagnose, manage, and treat patients with drug-induced ocular toxicity. This course will introduce those FDA drugs and their potential ocular toxicities with real-patient examples and overview how they should be managed. 11:20 AM – 12:10 PM Top 5 Cancers in the US – What it Means for the Patient in Your ChairJulia Canestraro, OD, FAAO 1 NJSBO TPA Credit – NJSBO # 662-2025 This course will cover how to screen for ocular manifestations of the top 5 most common cancers in the U.S., including their treatment and management. IMPORTANT INFORMATION REGARDING CE CREDIT:Courses presented at this event will be New Jersey State Board of Optometrists (NJSBO) and are non-COPE courses. Courses will be accepted for CE credit in NJ, NY, and PA. If you are licensed in any other state, please check with that state's Optometry Board to inquire if these courses will be accepted. Meet the Speakers  Tracy Offerdahl, PharmD, BPharm, RPh, FAAO Dr. Offerdahl attended Temple University School of Pharmacy in Philadelphia, Pennsylvania for both her undergraduate and graduate degrees. Upon completion of her Doctor of Pharmacy degree, she completed a residency at Temple University Hospital. She is currently on faculty at Salus University in the Department of Optometry, where she is the course director and instructor for all systemic pharmacology courses for students in the optometry, audiology, and physician assistant programs. Additionally, she is a practicing clinical pharmacist. Julia Canestraro, OD, FAAO Dr. Canestraro graduated from SUNY College of Optometry, and is currently an assistant attending optometrist at Memorial Sloan Kettering Cancer Center, Ophthalmic Oncology Service. She has experience in the diagnosis and non-surgical management of ocular disease, including ocular tumors. She also specializes in treating the ocular consequences of cancer and its treatments.    Industry Support! Sponsor Videos Check out this short PECAA member experience video from 2024 Diamond Partner, PECAA. View charitable eye care initiatives in a video from NJSOP Gold Partner, VSP. Learn about a contact lens option in a video from NJSOP Gold Partner, Johnson and Johnson.ACUVUE® OASYS MAX 1-Day contact lenses uses an unprecedented combination of technologies to deliver all-day comfort and visual clarity, day to night     NJSOP CE Event Registration Refund Policy  In the event an NJSOP continuing education event attendee wishes to rescind their event registration, refunds may be requested through email or by mail to NJSOP. Refund requests received at least 30 days or more before the event will receive a full refund. Requests made 14-29 days before the event will receive a 50% refund. Refunds will not be issued within 14 days of the event. However, registered attendees who experience an extenuating circumstance that prevents them from attending the event can request refund consideration via email or by mail. Refunds will be provided in the manner in which the registered attendee paid.       ----